Bereich
Intensivmedizin
MIPS · Dept. I
Cognitive Outcome 1 year after COVID-19 – A Pilot Study (CogCOVID)
19.10.2021This prospective observational pilot study examines cognitive function 1 year after SARS-Cov-2 disease. Study population consists of formerly hospitalized non-ventilated COVID-19 patients (nvCOVID) and ventilated patients with COVID-19-ARDS (cARDS) t...
Klinische Forschung - 19.10.2021 - 31.12.2022
Automatisch geschlossen
Projektleitung: Göhl-Freyn Kristina, Felbecker Ansgar
Mitarbeiter/innen: Albrich Werner, Schmid Dagmar, Kleger Gian-Reto, Schrag Claudia, Pietsch Urs
CRiPSI/CRiPSI-X: Covid-19 Risk Prediction in Swiss ICUs-Trial/Extension
01.08.2020Outcome of patients with critical Covid-19 varies. We study risk of and predictors for poor outcome in adult patients with Covid-19 admitted to ICU in a multicenter study. In addition, we assess the prevalence of, risk factors for and mechanisms invo...
Klinische Forschung - 01.08.2020 - 31.08.2022
Automatisch geschlossen
Projektleitung: Albrich Werner
Mitarbeiter/innen: Von Mering Christian, O'Mahony Liam, Cerny Andreas, Suh Noémie, El Baz Yassir, Dietrich Tobias, Fischer Tim, Felbecker Ansgar, Göhl-Freyn Kristina, Germann Nicolas, Schmid Dagmar, Kahlert Christian, Frischknecht Manuel, Filipovic Miodrag, Brutsche Martin, Pietsch Urs, Kleger Gian-Reto, Bochud Pierre-Yves
Immediate non-invasive ventilatory (NIV) support in patients with severe respiratory failure on the emergency ward (ED)- Experience of a 6 months pilot
01.06.2013Background Patients with severe respiratory failure (SRF) are often in need for rapid ventilatory support. Availability of immediate NIV is often limited to the intensive care unit (ICU). We hypothesized that immediate initiation of NIV in the ED is...
Grundlagenforschung - 01.06.2013 - 01.01.2015
Abgeschlossen
Projektleitung: Rüdiger Jochen, Brutsche Martin
Mitarbeiter/innen: Kleger Gian-Reto, Diethelm Markus, Osterwalder Joseph
Target temperature management 33º C versus 36ºC after out-of hospital cardiac arrest, a randomized, parallel group assessor blinded clinical trial
01.01.2012
Klinische Forschung - 01.01.2012 - 19.07.2012
Abgeschlossen
Projektleitung: Kleger Gian-Reto
Mitarbeiter/innen: Schmutz Franziska
Efficacy and safety of drotrecogin alfa (activated) in adult patients with septic shock
09.04.2009Coagulation disturbances are a mayor event in severe sepsis and septic shock. Activated protein C may reduce mortality in these patients by its antiinflammatory, antithrombotic and antifibrinolytic effect. However, bleeding complications are more fre...
Klinische Forschung - 09.04.2009 - 31.12.2011
Abgeschlossen
Projektleitung: Kleger Gian-Reto